AI Summary
In a new study, anti-arrhythmic drugs have been linked to the development of bradycardia and syncope in atrial fibrillation patients. This highlights potential risks associated with the use of these medications in this patient population.
A new study highlights the risks for syncope and bradycardia as potential side effects with anti-arrhythmic drugs when used for the treatment of atrial fibrillation.
Medscape Medical News